Company intelligence / Profile preview

Akesis

Concord, California, United Statesakesis.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Akesis develops and manufactures advanced stereotactic radiosurgery (SRS) and radiotherapy platforms that use patented rotational gamma technology and real-time imaging to deliver precise cancer treatments. Their flagship systems include the FDA-cleared Galaxy RTi/RTx and the modular Gemini360RT. These devices aim to improve treatment accuracy, patient throughput, and reduce collateral tissue damage in cancer care.

Therapeutic areas: OncologyNeurology
Modalities: DeviceRadiotherapy device (Gamma system, Linear accelerator)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Akesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akesis.

Explore the full profile